Learn More
Medchemexpress LLC Quinoline-2-carboxylic acid | 93-10-7 | 173.17 | 50 G

Supplier: Medchemexpress LLC HYW00201150G
Quinoline-2-carboxylic acid exhibits antidiabetic activity and can be used as a drug intermediate for the synthesis of various active compounds. It reduces the intestinal absorption of carbohydrates by inhibiting α-glucosidase and α-amylase (IC50 are 9.1 μg/mL and 15.5 μg/mL, respectively), thereby lowering postprandial blood glucose levels. This compound can also be used as a drug intermediate for the synthesis of compounds with antiallergic, apoptosis-inducing, or antiproliferative activities.
- Exhibits antidiabetic activity by reducing intestinal carbohydrate absorption.
- Inhibits α-glucosidase and α-amylase.
- Can be used as a drug intermediate for synthesis of compounds with antiallergic, apoptosis-inducing, or antiproliferative activities.
- Acts as a human endogenous metabolite.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.